Seeing Is Believing

Currently out of the existing stock ratings of Greg Harrison, 77 are a BUY (68.14%), 14 are a SELL (12.39%), 22 are a HOLD (19.47%).
Analyst Greg Harrison, carries an average stock price target met ratio of 56.21% that have a potential upside of 35.77% achieved within 179 days. Previously, Greg Harrison worked at BAML.
Greg Harrison’s has documented 219 price targets and ratings displayed on 27 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on LQDA, Liquidia Technologies at 29-Jun-2026.
Analyst best performing recommendations are on OMER (OMEROS).
The best stock recommendation documented was for APLS (APELLIS PHARMACEUTICALS) at 7/30/2025. The price target of $22 was fulfilled within 1 day with a profit of $3 (15.79%) receiving and performance score of 157.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6.25
$6.24 (62400.00%)
$25
4 years 1 months 14 days ago
(23-May-2022)
1/3 (33.33%)
$0.9 (16.82%)
14
Buy
$11
5 years 4 months 21 days ago
(17-Feb-2021)
1/1 (100%)
$-23.25 (-67.88%)
998
Buy
$125
$124.57 (28969.77%)
6 years 2 months ago
(08-May-2020)
0/1 (0%)
$54 (76.06%)
Which stock is Greg Harrison is most bullish on?
Which stock is Greg Harrison is most reserved on?
What Year was the first public recommendation made by Greg Harrison?